Introducing a Clinical Adoption Roadmap for Precision Cancer Care

On November 14, Personalized Medicine Coalition Senior Vice President for Science Policy Daryl Pritchard, Ph.D., will take the conference stage to introduce the Coalition’s new Roadmap for Addressing Clinical Practice Gaps in Precision Cancer Care.

The Roadmap will outline what the Coalition’s key partners, including but not limited to health system administrators, clinicians, guideline developers, and health insurance company executives, can do to bring the benefits of personalized medicine to more patients. By identifying the reforms necessary to encourage more consistent clinical practices in the United States and around the world, the Roadmap will be designed to help patients gain access to the tests and treatments that make personalized medicine possible.

As it stands, and as we know from PMC and Diaceutics’ research on the subject, personalized medicine benefits fewer than 40 percent of patients with such serious diseases as advanced non-small cell lung cancer.

Conference attendees will get the first look at the Coalition’s ambitious plan to reshape health care in the coming years for the benefit of patients and health systems.